172 related articles for article (PubMed ID: 2467224)
41. Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat.
Yoshimoto K; McBride WJ
Neurochem Res; 1992 May; 17(5):401-7. PubMed ID: 1356241
[TBL] [Abstract][Full Text] [Related]
42. Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm.
Martin P; Tissier MH; Adrien J; Puech AJ
Life Sci; 1991; 48(26):2505-11. PubMed ID: 1828519
[TBL] [Abstract][Full Text] [Related]
43. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain.
Bonvento G; Scatton B; Claustre Y; Rouquier L
Neurosci Lett; 1992 Mar; 137(1):101-4. PubMed ID: 1385646
[TBL] [Abstract][Full Text] [Related]
44. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
Marsden CA; Martin KF
Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
[TBL] [Abstract][Full Text] [Related]
45. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms of serotonergic affect control.
Kennett GA
Adv Exp Med Biol; 1991; 294():231-43. PubMed ID: 1685293
[No Abstract] [Full Text] [Related]
47. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
Söderpalm B; Hjorth S; Engel JA
Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
[TBL] [Abstract][Full Text] [Related]
48. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat.
Hillegaart V
Physiol Behav; 1990 Jul; 48(1):143-8. PubMed ID: 2146690
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM-3997.
Hirose A; Sasa M; Akaike A; Takaori S
Neuropharmacology; 1990 Feb; 29(2):93-101. PubMed ID: 1970426
[TBL] [Abstract][Full Text] [Related]
50. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis.
Hjorth S; Sharp T
Life Sci; 1991; 48(18):1779-86. PubMed ID: 1826937
[TBL] [Abstract][Full Text] [Related]
51. Effects of injections of 8-hydroxy-2-(di-n-propylamino)tetralin or muscimol in the median raphe nucleus on c-fos mRNA in the rat brain.
Funk D; Li Z; Fletcher PJ; Lê AD
Neuroscience; 2005; 131(2):475-9. PubMed ID: 15708488
[TBL] [Abstract][Full Text] [Related]
52. Median and dorsal raphe injections of the 5-HT1A agonist, 8-OH-DPAT, and the GABAA agonist, muscimol, increase voluntary ethanol intake in Wistar rats.
Tomkins DM; Sellers EM; Fletcher PJ
Neuropharmacology; 1994; 33(3-4):349-58. PubMed ID: 7984273
[TBL] [Abstract][Full Text] [Related]
53. A pharmacological analysis of the eating response induced by 8-OH-DPAT injected into the dorsal raphé nucleus reveals the involvement of a dopaminergic mechanism.
Fletcher PJ; Davies M
Psychopharmacology (Berl); 1990; 100(2):188-94. PubMed ID: 2137632
[TBL] [Abstract][Full Text] [Related]
54. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
[TBL] [Abstract][Full Text] [Related]
55. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
56. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
Adrien J; Lanfumey L; Gozlan H; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1989 Mar; 248(3):1222-30. PubMed ID: 2522986
[TBL] [Abstract][Full Text] [Related]
57. Effects of chronic diazepam treatment on pre- and postsynaptic 5-HT1A receptors in the rat brain.
Lanfumey L; Haj-Dahmane S; Laporte AM; Martin P; Hamon M; Gozlan H
Eur J Pharmacol; 1997 Apr; 323(2-3):137-48. PubMed ID: 9128832
[TBL] [Abstract][Full Text] [Related]
58. Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor.
Sinton CM; Fallon SL
Eur J Pharmacol; 1988 Nov; 157(2-3):173-81. PubMed ID: 2906291
[TBL] [Abstract][Full Text] [Related]
59. 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively.
Andrews N; Hogg S; Gonzalez LE; File SE
Eur J Pharmacol; 1994 Nov; 264(3):259-64. PubMed ID: 7698163
[TBL] [Abstract][Full Text] [Related]
60. Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors.
Schreiber R; Opitz K; Glaser T; De Vry J
Psychopharmacology (Berl); 1993; 112(1):100-10. PubMed ID: 7870997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
